Genprex

Tagged: Insulin

Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh

Latest license creates a comprehensive panel of gene therapies exclusively licensed by Genprex for the Company’s diabetes gene therapy program

Read More

Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh

Technologies Licensed from University of Pittsburgh May Have the Potential to Provide Long-Term Efficacy and to Change the Course of this Disease for the Millions of Patients Around the World with Type 1 or Type 2 Diabetes

Read More